Showing results (21-30 of 142) with videos related to
Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|July 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPCMichael I Sponfeldner, Wahram Andrikyan, Renke Maas, et al.European Journal of Clinical Pharmacology|October 24, 2012
Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristicsMartin F Fromm, Renke Maas, Thomas Tümena, et al.Metabolites|April 21, 2022
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/NactDaniela B Surrer, Martin F Fromm, Renke Maas, et al.Amino Acids|June 24, 2025
Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteinsLorenz A Scherpinski, Martin F Fromm, Renke Maas, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 12, 2026
Artificial intelligence-powered chatbots for oral anticancer drug patient information: an assessment of qualitySophie M Sametinger, Renke Maas, Hagen F Nicolaus, et al.BMC Health Services Research|April 4, 2016
Potentially inappropriate medication in the elderly in Germany: an economic appraisal of the PRISCUS listKatharina Pohl-Dernick, Florian Meier, Renke Maas, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2011
Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of L-homoarginine in human plasmaDorothee Atzler, Maren Mieth, Renke Maas, et al.International Journal of Molecular Sciences|April 3, 2014
Effect of lowering asymmetric dimethylarginine (ADMA) on vascular pathology in atherosclerotic ApoE-deficient mice with reduced renal massJohannes Jacobi, Renke Maas, Michaela Arend, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|October 31, 2024
Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1)Sofna Banjarnahor, Lorenz A Scherpinski, Max Keller, et al.British Journal of Clinical Pharmacology|November 13, 2007
P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery diseaseAnneke Bierend, Thomas Rau, Renke Maas, et al.Pageof 15